- Article metrics
- Last updated: Sat, 20 Apr 2024 8:12:22 Z
[18F]FDDNP performed better than [18F] Florbetapir to distinguish transthyretin cardiac amyloidosis (TTR-CA) patients from healthy controls: an ex vivo study
Access & Citations
-
- 657
- Article Accesses
-
- 0
- Web of Science
-
- 0
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.